home / stock / ljpc / ljpc short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 212,201 |
Total Actual Volume | 1,027,512 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 18 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 10,610 |
Average Short Percentage | 65.76% |
Is there a LJPC Short Squeeze or Breakout about to happen?
See the LJPC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-28 | 3.49 | 3.32 | 3.49 | 3.27 | 34,303 | 4,122 | 48.6831 |
2022-06-24 | 3.4 | 3.46 | 3.5 | 3.3661 | 55,584 | 6,531 | 43.9059 |
2022-06-23 | 3.38 | 3.38 | 3.4 | 3.32 | 32,882 | 8,851 | 83.5946 |
2022-06-22 | 3.37 | 3.38 | 3.39 | 3.37 | 23,801 | 1,722 | 59.4203 |
2022-06-21 | 3.43 | 3.39 | 3.48 | 3.338 | 66,380 | 11,786 | 66.4637 |
2022-06-16 | 3.16 | 3.47 | 3.47 | 3.1 | 79,212 | 14,900 | 54.9836 |
2022-06-15 | 3.26 | 3.2 | 3.349 | 3.12 | 76,781 | 19,699 | 63.6355 |
2022-06-14 | 3.49 | 3.28 | 3.56 | 3.28 | 50,048 | 14,856 | 64.3786 |
2022-06-13 | 3.4 | 3.5 | 3.57 | 3.4 | 51,372 | 10,877 | 81.0084 |
2022-06-09 | 3.75 | 3.68 | 3.81 | 3.68 | 41,884 | 6,230 | 57.2505 |
2022-06-08 | 3.77 | 3.77 | 3.83 | 3.7282 | 34,995 | 6,434 | 56.1039 |
2022-06-06 | 3.82 | 3.84 | 3.92 | 3.77 | 35,870 | 4,189 | 65.9477 |
2022-06-03 | 3.84 | 3.81 | 3.92 | 3.78 | 43,284 | 7,863 | 66.9248 |
2022-06-02 | 3.8602 | 3.85 | 3.9614 | 3.81 | 47,379 | 7,174 | 56.6443 |
2022-06-01 | 4.17 | 3.9 | 4.17 | 3.86 | 44,755 | 8,690 | 83.3174 |
2022-05-31 | 3.72 | 4.01 | 4.13 | 3.67 | 82,365 | 19,540 | 72.0847 |
2022-05-26 | 3.93 | 3.85 | 4.05 | 3.85 | 48,888 | 8,487 | 62.9880 |
2022-05-25 | 3.75 | 3.86 | 3.95 | 3.75 | 63,161 | 19,390 | 72.4616 |
2022-05-24 | 3.84 | 3.75 | 3.84 | 3.65 | 48,240 | 10,916 | 83.2710 |
2022-05-23 | 3.792 | 3.82 | 3.98 | 3.76 | 66,328 | 19,944 | 72.0963 |
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company (Nasdaq: LJPC) , which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results for the three months ended March 31, 2022 and highlighte...
La Jolla Pharmaceutical Company (Nasdaq: LJPC) , which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results for the three and twelve months ended December 31, 2021 ...
La Jolla Pharmaceutical Company (Nasdaq: LJPC) today announced that it will commence a share repurchase plan for up to $10 million of the Company’s common stock. Repurchases may be made from time to time at the Company’s discretion. The plan has no time limit and can b...